论文部分内容阅读
Objective Triple negative breast cancer (TNBC) contains a high proportion of breast cancer stem cells (BCSCs) and exhibits resistance to chemotherapy treatments. Therefore, the identification of BCSCs that are novel molecular targets may improve patient s